Luyan Pharma Co.,Ltd.

Shenzhen Stock Exchange 002788.SZ

Luyan Pharma Co.,Ltd. Gross Profit Margin for the year ending December 31, 2023: 7.59%

Luyan Pharma Co.,Ltd. Gross Profit Margin is 7.59% for the year ending December 31, 2023, a -2.49% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.

Luyan Pharma Co.,Ltd. Gross Profit Margin for the year ending December 31, 2022 was 7.79%, a -0.38% change year over year.
Luyan Pharma Co.,Ltd. Gross Profit Margin for the year ending December 31, 2021 was 7.82%, a -1.65% change year over year.
Luyan Pharma Co.,Ltd. Gross Profit Margin for the year ending December 31, 2020 was 7.95%, a 1.99% change year over year.
Luyan Pharma Co.,Ltd. Gross Profit Margin for the year ending December 31, 2019 was 7.79%, a -0.43% change year over year.

Key data

Date	Gross Profit Margin	Operating Income Margin	EBT Margin	Net Income Margin

Shenzhen Stock Exchange: 002788.SZ

Luyan Pharma Co.,Ltd.

CEO	Mr. Jinxiang Wu
IPO Date	Feb. 18, 2016
Location	China
Headquarters	No. 1004, Anling Road
Employees	5,475
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

Luyan Pharma Co.,Ltd. engages in the research and development, production, and sale of human health products in China. It also operates pharmaceutical distribution and retail direct stores. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen, China.

Key trends

Past 5 years